These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 33958879)

  • 1. In vitro Antimicrobial Synergy Testing of Extensively Drug-Resistant Clinical Isolates at an Organ Transplant Center in Nepal.
    Karki R; Lamichhane S; Basnet BB; Dahal A; Awal BK; Mishra SK
    Infect Drug Resist; 2021; 14():1669-1677. PubMed ID: 33958879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic resistance and detection of plasmid mediated colistin resistance mcr-1 gene among Escherichia coli and Klebsiella pneumoniae isolated from clinical samples.
    Karki D; Dhungel B; Bhandari S; Kunwar A; Joshi PR; Shrestha B; Rijal KR; Ghimire P; Banjara MR
    Gut Pathog; 2021 Jul; 13(1):45. PubMed ID: 34225805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended spectrum beta-lactamase and metallo beta-lactamase production among Escherichia coli and Klebsiella pneumoniae isolated from different clinical samples in a tertiary care hospital in Kathmandu, Nepal.
    Nepal K; Pant ND; Neupane B; Belbase A; Baidhya R; Shrestha RK; Lekhak B; Bhatta DR; Jha B
    Ann Clin Microbiol Antimicrob; 2017 Sep; 16(1):62. PubMed ID: 28927454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro antimicrobial susceptibility of clinical respiratory isolates to ceftazidime-avibactam and comparators (2016-2018).
    Piérard D; Stone GG
    BMC Infect Dis; 2021 Jun; 21(1):600. PubMed ID: 34162341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.
    Decousser JW; Woerther PL; Soussy CJ; Fines-Guyon M; Dowzicky MJ
    Antimicrob Resist Infect Control; 2018; 7():68. PubMed ID: 29876099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparative
    Singh S; Sahu C; Patel SS; Singh A; Yaduvanshi N
    Indian J Crit Care Med; 2020 Dec; 24(12):1213-1217. PubMed ID: 33446975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-Kill Evaluation of Antibiotic Combinations Containing Ceftazidime-Avibactam against Extensively Drug-Resistant Pseudomonas aeruginosa and Their Potential Role against Ceftazidime-Avibactam-Resistant Isolates.
    Montero MM; Domene Ochoa S; López-Causapé C; Luque S; Sorlí L; Campillo N; López Montesinos I; Padilla E; Prim N; Angulo-Brunet A; Grau S; Oliver A; Horcajada JP
    Microbiol Spectr; 2021 Sep; 9(1):e0058521. PubMed ID: 34319141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
    Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates.
    Samonis G; Maraki S; Karageorgopoulos DE; Vouloumanou EK; Falagas ME
    Eur J Clin Microbiol Infect Dis; 2012 May; 31(5):695-701. PubMed ID: 21805292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro Synergistic Effects of Antimicrobial Combinations on Extensively Drug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Isolates.
    Lee H; Roh KH; Hong SG; Shin HB; Jeong SH; Song W; Uh Y; Yong D; Lee K
    Ann Lab Med; 2016 Mar; 36(2):138-44. PubMed ID: 26709261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the in vitro activity of ceftazidime/avibactam against a global collection of multidrug-resistant Klebsiella spp. from the INFORM surveillance programme (2015-2017).
    Rossolini GM; Stone GG
    Int J Antimicrob Agents; 2020 Sep; 56(3):106111. PubMed ID: 32721602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effect and antibiofilm activity of the antimicrobial peptide K11 with conventional antibiotics against multidrug-resistant and extensively drug-resistant
    Chatupheeraphat C; Peamchai J; Luk-In S; Eiamphungporn W
    Front Cell Infect Microbiol; 2023; 13():1153868. PubMed ID: 37113135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug-resistant and extensively drug-resistant Gram-negative prosthetic joint infections: Role of surgery and impact of colistin administration.
    Papadopoulos A; Ribera A; Mavrogenis AF; Rodriguez-Pardo D; Bonnet E; Salles MJ; Dolores Del Toro M; Nguyen S; Blanco-García A; Skaliczki G; Soriano A; Benito N; Petersdorf S; Pasticci MB; Tattevin P; Tufan ZK; Chan M; O'Connell N; Pantazis N; Kyprianou A; Pigrau C; Megaloikonomos PD; Senneville E; Ariza J; Papagelopoulos PJ; Giannitsioti E;
    Int J Antimicrob Agents; 2019 Mar; 53(3):294-301. PubMed ID: 30395988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community acquired multi-drug resistant clinical isolates of Escherichia coli in a tertiary care center of Nepal.
    Ansari S; Nepal HP; Gautam R; Shrestha S; Neopane P; Gurung G; Chapagain ML
    Antimicrob Resist Infect Control; 2015; 4():15. PubMed ID: 25937923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of ceftaroline alone and in combination against clinical isolates of resistant gram-negative pathogens, including beta-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa.
    Vidaillac C; Leonard SN; Sader HS; Jones RN; Rybak MJ
    Antimicrob Agents Chemother; 2009 Jun; 53(6):2360-6. PubMed ID: 19349512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of Drug-Resistant Bacteria in a General Hospital, China, 2011-2016.
    Mao T; Zhai H; Duan G; Yang H
    Pol J Microbiol; 2019; 68(2):225-232. PubMed ID: 31250593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro synergistic activity of colistin and meropenem against clinical isolates of carbapenem resistant E.coli and Klebsiella pneumoniae by checkerboard method.
    Dhandapani S; Sistla S; Gunalan A; Manoharan M; Sugumar M; Sastry AS
    Indian J Med Microbiol; 2021 Jan; 39(1):6-10. PubMed ID: 33516606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of CTX-M
    Koirala S; Khadka S; Sapkota S; Sharma S; Khanal S; Thapa A; Khadka DK; Poudel P
    Biomed Res Int; 2021; 2021():9958294. PubMed ID: 34212045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effect of two antimicrobial peptides, Nisin and P10 with conventional antibiotics against extensively drug-resistant Acinetobacter baumannii and colistin-resistant Pseudomonas aeruginosa isolates.
    Jahangiri A; Neshani A; Mirhosseini SA; Ghazvini K; Zare H; Sedighian H
    Microb Pathog; 2021 Jan; 150():104700. PubMed ID: 33346078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.